Fund profile · Compiled from public sources

AV Venture

San Francisco, USA · Seed → Series B

Their stated focus (public profile)

ARTIS invests in frontier technologies aimed at transforming the human condition, focusing on the convergence of biology, healthcare, data, and AI. The fund backs visionary founders reimagining systems vital to human life, from the cellular to the societal, with emphasis on TechBio, Tech + Health, and Frontier Tech. It supports breakthroughs in areas such as AI-driven healthcare, genomics, therapeutics, and precision medicine to make health proactive, personalized, and resilient.

Stages: Seed → Series B

Sectors: Healthtech, Life sciences, AI / ML, Femtech / women's health, Microbiome, Medtech, Foodtech, Defense

On file: 6 partners on record · 40 companies on record

Website: av.co

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →